Ligand Pharmaceuticals Inc (LGND)

[georgie18]

https://www.otcmarkets.com/stock/LGNDZ/overview

Rights - Roche Contingent Value Right...Stated right under the name to clarify what it is...Clear as day what this is...

Penny Stock Exempt stated on the right hand side of the page...

Share Structure is not available because there are no common shares...there are rights which are just like options...

https://www.otcmarkets.com/stock/LGND/overview

LGND is the Naz company that is issuing the rights that trades at $98...and the ticker that represents LGND common shares...

Look at all the News under LGNDZ do you see LGNDZ mentioned once as the headline on the news...No...There is a clear reason for that...

Ligand Pharmaceuticals Is A Lower Risk Biotech With A Cash Generative And Diversified Business ModelSeeking Alpha | 09/25/2019
Ligand Pharmaceuticals (LGND) Presents At H.C. Wainwright 21st Annual Global Investment Conference - SlideshowSeeking Alpha | 09/16/2019
Ligand Pharmaceuticals And The OmniAb PlatformSeeking Alpha | 09/06/2019
Ligand to Participate in the H. C. Wainwright 21st Annual Global Investment ConferenceBUSINESS WIRE | 08/29/2019
Healthcare And Biotechnology Dashboard - UpdateSeeking Alpha | 08/16/2019
Ligand Partner CASI Pharmaceuticals Launches EVOMELA® in ChinaBUSINESS WIRE | 08/12/2019
Insider Weekends: A Second Group Of AbbVie Insiders Purchase SharesSeeking Alpha | 08/06/2019
Lemelson Capital Increases Short Position in Ligand Pharmaceuticals (NASDAQ: LGND), Calls on US Attorney to InvestigatePR NEWSWIRE | 07/30/2019
Ligand Pharmaceuticals' (LGND) CEO John Higgins on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha | 07/30/2019
Ligand Pharma down 11% on pipeline concernsSeeking Alpha | 07/30/2019

Just call the Investor Relations and ask them...easy enough to do...


Not saying this may not run because if the rights meet the target it certainly will but you cannot confuse the fact that the share structure and the buyback you are posting as LGNDZ is actually for LGND...The "Z" is for the CVR / Contingent Value Rights...